Xiuqi Wu

Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma

Xingliang Guo, Hua Jiang, Bizhi Shi et al. · Frontiers in Pharmacology · 2018 · 205 citations · Full text

Medicine, Immunology, Oncology +17

Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

Min Yu, Hong Luo, Mingliang Fan et al. · Molecular Therapy · 2017 · 185 citations · Full text

Life Sciences, Immunology, Oncology +16

Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma

Xiuqi Wu, Hong Luo, Bizhi Shi et al. · Molecular Therapy · 2019 · 157 citations · Full text

Medicine, Oncology, Pharmacology +17

Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma

Ying Liu, Shengmeng Di, Bizhi Shi et al. · The Journal of Immunology · 2019 · 140 citations

Medicine, Immunology, Oncology +17

EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer

Jiqin Zhang, Fei Song, Xiaojing Zhao et al. · Molecular Cancer · 2017 · 99 citations · Full text

Life Sciences, Cancer Biology, Oncology +17